ONdrugDelivery - Page 2 of 62 - ONdrugDelivery - drug delivery industry specialised b2b information

COMPREHENSIVE TESTING PROVES DESIGN CONCEPT OF NOVEL AUTOINJECTOR PLATFORM

Dr Farid Seddighi

COMPREHENSIVE TESTING PROVES DESIGN CONCEPT OF NOVEL AUTOINJECTOR PLATFORM

Farid Seddighi, Sigrid Saaler-Reinhardt and Daniel Primavessy discuss the critical importance of testing at an early stage of medical device development, presenting an overview of the results that confirm the technical performance and usability of the novel Gx Inbeneo^® autoinjector.

DEFINING HIGH-VISCOSITY, LARGE-VOLUME DRUG DELIVERY SYSTEMS

DEFINING HIGH-VISCOSITY, LARGE-VOLUME DRUG DELIVERY SYSTEMS

Kyle Toole, Blair Hutton and James McLusky discuss the value that mathematical modelling can provide in the early stages of injectable drug delivery device development, especially when coupled with appropriate empirical testing in a laboratory setting.

IT’S TIME TO CONSIDER INTRADERMAL DELIVERY

Dr Nicky Bertollo

IT’S TIME TO CONSIDER INTRADERMAL DELIVERY

Nicky Bertollo, Adam Rock and Saidhbh O’Callaghan discuss the progress Pharma Latch’s intradermal drug delivery platform is making towards realising the potential the intradermal route offers to drug developers, especially for vaccines.

NAVIGATING THE AI REVOLUTION IN THE MEDICAL DEVICES SECTOR: BETWEEN INNOVATION AND REGULATION

NAVIGATING THE AI REVOLUTION IN THE MEDICAL DEVICES SECTOR: BETWEEN INNOVATION AND REGULATION

Timothy Bubb discusses the potential impact of artificial intelligence and machine learning on the healthcare and drug delivery industries, with an overview of the differing regulatory approaches taken by the EU, US FDA and UK MHRA towards this novel area of digital health.

PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY

Philipp Ludihuser

PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY

Philipp Ludihuser and Arne Kloke highlight how SCHOTT Pharma’s collaboration with customers and partners in the pharmaceutical industry reduces the carbon emissions from the production of vials, cartridges, ampoules and syringes, as well as introducing circular solutions to increase resource efficiency.

Interview with Bespak’s Louise Righton & Benedicta Bakpa

Interview with Bespak’s Louise Righton & Benedicta Bakpa

An increasing global incidence of respiratory diseases, such as asthma and COPD, is driving demand for therapies. Simultaneously, greenhouse gas emissions continue to rise, so the pharma industry must consider how to produce much-needed nasally delivered and orally inhaled medicines whilst minimising environmental impact. Louise Righton and Benedicta Bakpa discuss the many different aspects involved in driving sustainability in inhaled drug delivery – and the next steps.

PRIORITISING SUSTAINABILITY IN PHARMA

PRIORITISING SUSTAINABILITY IN PHARMA

Jessica Buday discusses how, in partnership with West Pharmaceutical Services, Corning’s Viridian glass vials are able to simultaneously improve the sustainability and efficiency of pharmaceutical fill-finish lines compared with traditional ISO glass vials, due to their reduced glass volume and proprietary external polymeric coating.

OPPORTUNITY THROUGH INNOVATION – ENVIRONMENTAL AND SOCIAL SUSTAINABILITY IN INJECTION DEVICES

Credence MedSystems

OPPORTUNITY THROUGH INNOVATION – ENVIRONMENTAL AND SOCIAL SUSTAINABILITY IN INJECTION DEVICES

John Merhige and Dan Thayer discuss how the successful implementation of ESG principles in the pharmaceutical sector requires innovation that allows sustainability to be seen as an opportunity rather than a burden. Furthermore, the authors present the case that improving on the social aspect of ESG is just as important as improving on the environmental side.

INTERVIEW with GLENN SVEDBERG

INTERVIEW with GLENN SVEDBERG

Glenn Svedberg engages in a wide-ranging discussion around the role and importance of sustainability in the drug delivery industry, and how Nolato Group has approached implementing this critical aspect of the modern industry landscape. Mr Svedberg considers how sustainability factors play into the relationship between CDMOs like Nolato and pharma companies, the importance of materials and how to drive forward sustainability goals within pharma and drug delivery.

CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY

CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY

David Pircher provides insights from a sustainability journey, showcasing what suppliers can contribute and how innovation and partnership support a common vision. The article outlines where the industry stands and why sustainability is a top priority, with concrete examples.

FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK

FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK

Herman Rusch and Steven van Voorst discuss the steps that IGS GeboJagema has taken to provide its ESG efforts with a robust structure to build on and how doing so has made those efforts more effective and provided the company with clear, meaningful and measurable targets to work towards.

CONFERENCE SHOWCASE

DIVE INTO THE HEART OF PHARMA ”CELEBRATING 35 YEARS OF CPHI”

Join colleagues from across the industry at CPHI Milan 2024, the premier global event for pharmaceutical professionals, from October 8–10, 2024, at Fiera Milano in Milan, Italy.

SUSTAINABLE DESIGN FOR HEALTHCARE DEVICES: PATHWAYS TOWARDS NET ZERO

SUSTAINABLE DESIGN FOR HEALTHCARE DEVICES: PATHWAYS TOWARDS NET ZERO

Will Davies and Holly Milston consider sustainable pathways towards circularity in the medical device industry.

ENABLING LARGE-VOLUME SUBCUTANEOUS INJECTION WITH A SMART WEARABLE INJECTION PLATFORM

Altek Biotechnology

ENABLING LARGE-VOLUME SUBCUTANEOUS INJECTION WITH A SMART WEARABLE INJECTION PLATFORM

Leonard Chu presents the Altek Biotechnology's Alby injection platform and highlights its versatility as a delivery platform for large-volume subcutaneous injections.

TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING

TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING

Greg Moakes and Tzach Sadi the process and benefits of automating the production process for its on-body injector device, Sorrel™.

SYMBIOZE<sup>®</sup>: LARGE-VOLUME ON-BODY INJECTOR PLATFORM FOSTERING PATIENTS’ EXPERIENCE

SYMBIOZE^®: LARGE-VOLUME ON-BODY INJECTOR PLATFORM FOSTERING PATIENTS’ EXPERIENCE

Cécile Gross and Mark Tunkel discuss the how Nemera's on-body injector platform – Symbioze^® – has been developed by drawing on a combination of lessons learned from the history of injection devices and the company’s extensive experience developing drug delivery devices for the parenteral route.

UNLOCKING OPPORTUNITIES IN ON-BODY DELIVERY SYSTEMS THROUGH A PLATFORM TECHNOLOGY APPROACH

Stevanato Group

UNLOCKING OPPORTUNITIES IN ON-BODY DELIVERY SYSTEMS THROUGH A PLATFORM TECHNOLOGY APPROACH

Anna Allegro and Andrea Cuccato discuss how Stevanato’s Vertiva^® on-body delivery system exemplifies a platform technology approach to device design, with its 3 and 10 mL formats providing the flexibility necessary to accommodate a wide variety of therapies.

THE IMPORTANCE OF USER-CENTRIC DESIGN WHEN DEVELOPING DEVICES FOR HOME USE

THE IMPORTANCE OF USER-CENTRIC DESIGN WHEN DEVELOPING DEVICES FOR HOME USE

Simon Bürdel and Reza Abedian, discuss the importance and value of conducting human factors studies and user consultations above and beyond regulatory requirements when designing user-centric devices for subcutaneous self-injection in at-home settings.

CCBio’s Quick Dose On-Body Injector

CCBio’s Quick Dose On-Body Injector

Quick Dose is a reusable on-body injector designed and developed to address the challenges of drug container compatibility and extend the lifecycle. The device aims to provide a more efficient and comfortable drug delivery method for patients and meet evolving market needs.

FROM PRECISION TO PERFECTION: NEW ON-BODY DELIVERY SYSTEM TESTING SOLUTIONS

FROM PRECISION TO PERFECTION: NEW ON-BODY DELIVERY SYSTEM TESTING SOLUTIONS

Peter Schmidt details the advantages ZwickRoell’s integrated testing systems offer for ensuring precise and accurate testing of on-body drug delivery systems, including the prevention of static charge and the company’s advanced camera-based measurement systems.

ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY

Enable Injections

ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY

Omar Rahman, Beth Faiman and Lisa Gorski highlight the importance of a comfortable experience for both patients and healthcare providers when it comes to large-volume subcutaneous drug delivery.

TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS

Dr Andrea Allmendinger

TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS

Andrea Allmendinger, Michael Adler, Carole Delauney and Hanns-Christian Mahler provide an overview of large-volume wearable injection devices for the subcutaneous delivery of biologics and discuss the technical challenges associated with the development and manufacturing of these drug/device combination products.

DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE

Dr Chaoyoung Lee

DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE

Chaoyoung Lee and Mike Stout introduce the Horizon wearable micro-pump platform, a cutting-edge advancement in the drug delivery device market that marks a significant contribution to wearable drug-device design.

THE SPECIFIC APPROACH: THE ADVANTAGE OF CUSTOMISATION FOR WEARABLE DELIVERY SYSTEMS

Dave Beckstoffer

THE SPECIFIC APPROACH: THE ADVANTAGE OF CUSTOMISATION FOR WEARABLE DELIVERY SYSTEMS

Dave Beckstoffer considers how involving customisation from the outset of an on-body injector development project can not only optimise the patient outcome but also streamline the development timescale for device engineers, with a particular focus on the drive system.

Prev
1
2
3
4
…
62
Next

See what ondrugdelivery's readers and contributors think

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.

Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.

Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Top